Fraser Wright - Spark Therapeutics Insider

Spark Therapeutics Inc -- Germany Stock  

EUR 44.26  0.63  1.40%

Co-Founder and CTO

Dr. J. Fraser Wright Ph.D. is CoFounder and Chief Technology Officer of Spark Therapeutics Inc. From July 2013 until he joined Spark Dr. Wright served as our Chief Technology Advisor. Dr. Wright established and had been the director of the Clinical Vector Core Laboratory at CHOP from 2004 to January 2015. Dr. Wright also was a Professor at the Perelman School of Medicine at the University of Pennsylvania. Dr. Wright previously served as Director of Development and Clinical Manufacturing at Avigen Inc. from 1999 to 2004 and as scientist with Sanofi Pasteur and as scholar investigator with the Canadian blood services
Age: 56  Founder Since 2015  Ph.D    
Wright received his B.S. and Ph.D. in biochemistry from the University of Toronto.

Management Efficiency

The company has return on total asset (ROA) of (24.8) % which means that it has lost $24.8 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (49.14) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.3 M in total debt with debt to equity ratio (D/E) of 0.2 which may suggest the company is not taking enough advantage from borrowing. Spark Therapeutics Inc has Current Ratio of 15.47 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

Spark Therapeutics Inc (272) is traded on Frankfurt Stock Exchange in Germany. and employs 27 people.

Did you try this?

Run Cryptocurrency Correlation Now

Cryptocurrency Correlation

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges
Hide  View All  NextLaunch Cryptocurrency Correlation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Spark Therapeutics Inc to your portfolio

Top Management

Spark Therapeutics Inc Leadership Team
Romuald Corbau, Executive
Carol GrevePhilips, Executive
Robert Perez, Director
Lars Ekman, Director, Ph.D
Jennifer Wellman, Founder
Fraser Wright, Founder, Ph.D
Lorris Betz, Director
Morgan Molloy, Executive
Joseph Barge, Executive
Katherine High, President, Ph.D
Elliot Sigal, Director
John Furey, COO, MBA
Vincent Milano, Director
Lota Zoth, Director
Rogerio Coelho, Executive
Guang Qu, Executive
Daniel Takefman, Executive, Ph.D
Stephen Webster, CFO, MBA
Rogerio Vivaldi, Executive
Diane Blumenthal, Executive, MBA
Jeffrey Marrazzo, CEO, MBA
Daniel Faga, Executive, MBA
Anand Mehra, Director
Linda Hearne, Executive, MBA
Paul Gil, Executive, MBA
Charles Sigal, Director
Federico Mingozzi, Executive
Steven Altschuler, Chairman
Lisa Dalton, Executive, MBA

Stock Performance

Spark Therapeutics Performance Indicators